Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Parkinson's Disease (PD) · Parkinson's Disease · Parkinson's Disease (Disorder)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Invicro (dba Perceptive), New Haven, Connecticut, United States
Contact: Study coordinator (David Russell, M.D., Ph.D) · learnmore@perceptive.com · 203-401-4300
XingImaging LLC, New Haven, Connecticut, United States
Contact: Study coordinator (Clinical Research Coordinator) · asynstudy@xingimaging.com · 475-318-8250
Contact: Principal Investigator (Neha Prakash, MBBS)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Parkinson's Disease

Abroad (travel likely)RecruitingPHASE1

Austin, United States · Tōon, Japan

Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

Parkinson Disease · Parkinson's Disease

Abroad (travel likely)RecruitingPHASE1

Seoul, South Korea

Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training

Parkinson's Disease · Mild Cognitive Impairment

Abroad (travel likely)Recruiting

Zurich, Switzerland

Molecular and Functional Imaging in Monogenic PD.

Parkinson Disease · Nervous System Disorder · Neurodegenerative Diseases

Abroad (travel likely)Recruiting

Exeter, United Kingdom